| CCC | I407 |
| ATCC | MDA-MB-231 |
MDA-MB-231 cell line is another widely studied human cancer cell line, specifically derived from a 51-year-old African American female patient with invasive ductal breast carcinoma in 1973. These cells are categorized as a triple-negative breast cancer cell line, lacking estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression.
MDA-MB-231 cells are known for their highly aggressive, invasive, and metastatic characteristics in preclinical models, making them a valuable tool for investigating breast cancer biology, tumor progression, angiogenesis, drug resistance mechanisms, and potential therapeutic strategies.
the MDA-MB-231 cell line has played a crucial role in advancing our understanding of breast cancer biology and therapeutic development, serving as an important model for studying aggressive and difficult-to-treat cancer subtypes like triple-negative breast cancer.
Organism species: Homo sapiens (Human)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Cells | CSI407Hu11 | Human MDA-MB-231 | MDA-MB-231 cell line is a valuable tool for investigating breast cancer biology, tumor progression, angiogenesis, drug resistance mechanisms, and potential therapeutic strategies |
| CSI407Hu12 | Human MDA-MB-231 | MDA-MB-231-GFP-luc cells carry GFP and luciferase genes through lentiviral transfection, and can stably express firefly luciferase and green fluorescent protein. | |
| Extracts | n/a | Extract of MDA-MB-231 | Total Protein/DNA/RNA Extract Customized Service Offer |
| Mediums | n/a | Medium for MDA-MB-231 (If Necessary) | Cell Culture Medium Customized Service Offer |